Trademark Overview
On Monday, May 12, 2025, a trademark application was filed for KENNIE MEDS with the United States Patent and Trademark Office. The USPTO has given the KENNIE MEDS trademark a serial number of 99179929. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, May 12, 2025. The KENNIE MEDS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, ibuprofen tablets; acetaminophen tablets; bismuth subsalicylate tablets; famotidine tablets; calcium carbonate tablets; diphenhydramine tablets; guaifenesin tablets; loperamide tablets; hydrocortisone topical cream; fluticasone nasal spray; oxymetazoline nasal spray; saline nasal spray; liquid acetaminophen for children; liquid ibuprofen for children; liquid guaifenesin; azithromycin prescription tablets; ondansetron prescription tablets; cephalexin prescription tablets; hangover herbal supplement capsules; cold and flu herbal supplement capsules; and scopolamine patches.